You have 9 free searches left this month | for more free features.

Condition

BK Virus (1)

Kidney Transplant Immunosuppression (1)

Kidney Transplant Recipients (1)

Rheumatoid Arthritis (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 4 (2)

phase 3 (1)

Sponsor

Lee's Pharmaceutical Limited (2)

Sanofi (1)

Collaborator

Regeneron Pharmaceuticals (1)

Intervention

mizoribine (3)

bucillamine (1)

leflunomide (1)

mycophenolate mofetil (1)

sarilumab (1)

sulfasalazine (1)

tacrolimus (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

mizoribine

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Kidney Transplant Immunosuppression Trial in China (Mizoribine, Mycophenolate Mofetil)

Recruiting

Kidney Transplant Immunosuppression

Mizoribine
Mycophenolate Mofetil

Nanning, Guangxi, China
+5 more

Oct 30, 2023

Kidney Transplant Recipients, BK Virus Trial in Guangzhou (Mizoribine)

Not yet recruiting

Kidney Transplant Recipients
BK Virus

Mizoribine

Guangzhou, China

The First Affiliated Hospital of Sun Yat-sen University

Mar 22, 2022

Rheumatoid Arthritis Trial in Japan (Sarilumab, Sulfasalazine, Leflunomide)

Completed

Has Results

Rheumatoid Arthritis

Sarilumab
+5 more

Asahi-Shi, Japan
+39 more

Jan 5, 2018